Oriental medicine Jangwonhwan reduces Aβ(1-42) level and β-amyloid deposition in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease

Journal of Ethnopharmacology

Volumn 128, Issue 1, 2010, Pages 206-212

  Seo, Ji Seon ^a   Yun, Jong Hyun ^b   Baek, In Sun ^a   Leem, Yeo Hyun ^a   Kang, Hyung Won ^b   Cho, Hyoung Kwon ^c   Lyu, Yeoung Su ^b   Son, Hyung Jin ^a   Han, Pyung Lim ^a  

^a Ewha Womans University   (South Korea)

^b Wonkwang University   (South Korea)

^c Hanpoong Pharm Research Center   (South Korea)

Author keywords

amyloid plaque; A ; Alzheimer disease; Angelica gigas Nakai; LMK02 Jangwonhwan; Oriental medicine; Panax ginseng C.A. Meyer

Indexed keywords

ACORUS GRAMINEUS EXTRACT; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; ANGELICA GIGAS EXTRACT; CALBINDIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GINSENG EXTRACT; HERBACEOUS AGENT; JANGWONHWAN; LMK 02; NEUROPROTECTIVE AGENT; OPHIOPOGON JAPONICAS EXTRACT; PLANT EXTRACT; PORIA COCOS EXTRACT; SCROPHULARIA BUERGERIANA EXTRACT; THUJA ORIENTALIS EXTRACT; UNCLASSIFIED DRUG;

ACORUS; ACORUS GRAMINEUS; ALZHEIMER DISEASE; ANGELICA; ANGELICA GIGAS; ANIMAL CELL; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG MIXTURE; DRUG SCREENING; FEMALE; GINSENG; HIPPOCAMPUS; IN VITRO STUDY; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; OPHIOPOGON JAPONICAS; OXIDATIVE STRESS; PORIA COCOS; SCROPHULARIA BUERGERIANA; SCROPHULARIACEAE; SENILE PLAQUE; THUJA; THUJA ORIENTALIS;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS;

ANGELICA GIGAS; MUS; MUS MUSCULUS; PANAX GINSENG;

EID: 76749090929     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.01.014     Document Type: Article

References (34)

1. Balasubramanyam M., Koteswari A.A., Kumar R.S., Monickaraj S.F., Maheswari J.U., Mohan V. Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications. Journal of Biosciences 2003, 29:715-721.
2. Bastianetto S., Quirion R. Natural antioxidants and neurodegenerative diseases. Frontiers in Bioscience 2004, 9:3447-3452.
3. Bazan N.G., Palacios-Pelaez R., Lukiw W.J. Hypoxia signaling to genes: significance in Alzheimer's disease. Molecular Neurobiology 2002, 26:283-298.
4. Bertram L., Tanzi R.E. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nature Reviews Neuroscience 2008, 9:768-778.
5. Chan W.H., Wu H.J., Hsuuw Y.D. Curcumin inhibits ROS formation and apoptosis in methylglyoxal-treated human hepatoma G2 cells. Annals of the New York Academy of Sciences 2005, 1042:372-378.
6. Cho I.H., Im J.Y., Kim D., Kim K.S., Lee J.K., Han P.L. Protective effects of extracellular glutathione against Zn2+-induced cell death in vitro and in vivo. Journal of Neuroscience Research 2003, 74:736-743.
7. dos Santos-Neto L.L., de Vilhena Toledo M.A., Medeiros-Souza P., de Souza G.A. The use of herbal medicine in Alzheimer's disease. Evidence-based Complementary and Alternative Medicine 2006, 3:441-445.
8. Finch C.E., Morgan T.E. Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: as position paper. Current Alzheimer Research 2007, 4:185-189.
9. Frank B., Gupta S. A review of antioxidants and Alzheimer's disease. Annals of Clinical Psychiatry 2005, 17:269-286.
10. Ghosh A.K., Hong L., Tang J. Beta-secretase as a therapeutic target for inhibitor drugs. Current Medicinal Chemistry 2002, 9:1135-1144.
11. Goedert M., Spillantini M.G. A century of Alzheimer's disease. Science 2006, 314:777-781.
12. Hills I.D., Vacca J.P. Progress toward a practical BACE-1 inhibitor. Current Opinion in Drug Discovery & Development 2007, 10:383-391.
13. Huh, J., 1610. Donguibogam. Reprinted by Namsandang Press in 1994, Seoul.
14. Iacopino A.M., Christakos S. Specific reduction of calcium binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:4078-4082.
15. Im J.Y., Kim D., Paik S.G., Han P.L. Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation. Free Radical Biology & Medicine 2006, 41:960-972.
16. Imbimbo B.P. Therapeutic potential of gamma-secretase inhibitors and modulators. Current Topics in Medicinal Chemistry 2008, 8:54-61.
17. Jankowsky J.L., Slunt H.H., Ratovitski T., Jenkins N.A., Copeland N.G., Borchelt D.R. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomolecular Engineering 2001, 17:157-165.
18. Korea Food and Drug Administration The Korean Pharmacopoeia IX 2008, Sinnilbooks Press Inc., Seoul. ninth ed.
19. Korea Food and Drug Administration Korean Pharmaceutical Codex 2007, Sinnilbooks Press Inc., Seoul, p 1533. third ed.
20. Lee K.W., Lee S.H., Kim H., Song J.-S., Yang S.-D., Paik S.G., Han P.L. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein. Journal of Neuroscience Research 2004, 76:572-580.
21. Lee K.W., Im J.Y., Song J.S., Lee S.H., Lee H.J., Ha H.Y., Koh J.Y., Gwag B.J., Yang S.D., Paik S.G., Han P.L. Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein. Neurobiology of Disease 2006, 22:10-24.
22. Lee K.W., Kim J.B., Seo J.S., Kim T.K., Im J.Y., Baek I.S., Kim K.S., Lee J.K., Han P.L. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress. Journal of Neurochemistry 2009, 108:165-175.
23. Lee, B., Choi, E.J., Lee, E.J., Han, S.M., Hahm, D.H., Lee, H.J., Shim, I., in press. The neuroprotective effect of methanol extract of Gagamjungjihwan and Fructus Euodiae on ischemia-induced neuronal and cognitive impairment in the rat. Evidence-based Complementary and Alternative Medicine.
24. Leuba G., Kraftsik R., Saini K. Quantitative distribution of parvalbumin, calretinin, and calbindin D-28k immunoreactive neurons in the visual cortex of normal and Alzheimer cases. Experimental Neurology 1998, 152:278-291.
25. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. Journal of Neuroscience 2001, 21:8370-8377.
26. Palop J.J., Jones B., Kekonius L., Chin J., Yu G.Q. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:9572-9577.
27. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. The FASEB Journal 2008, 22:659-661.
28. Selkoe D.J., Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annual Review of Pharmacology and Toxicology 2003, 43:545-584.
29. Seo J.S., Kim T.K., Leem Y.H., Lee K.W., Park S.K., Baek I.S., Kim S.K., Im G.J., Lee S.M., Park Y.H., Han P.L. SK-PC-B70 M confers anti-oxidant activity and reduces Aβ levels in the brain of Tg2576 mice. Brain Research 2009, 1261:100-108.
30. Smith J.V., Luo Y. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. Journal of Alzheimer's Disease 2003, 5:287-300.
31. Stackman R.W., Eckenstein F., Frei B., Kulhanek D., Nowlin J., Quinn J.F. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Experimental Neurology 2003, 184:510-520.
32. Yamamoto-Sasaki M., Ozawa H., Saito T., Rosler M., Riederer P. Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Research 1999, 824:300-303.
33. Yu Y.M., Han P.L., Lee J.K. JNK pathway is required for retinoic acid-induced neurite outgrowth of human neuroblastoma, SH-SY5Y. Neuroreport 2003, 14:941-945.
34. Zhu X., Su B., Wang X., Smith M.A., Perry G. Causes of oxidative stress in Alzheimer disease. Cellular and Molecular Life Sciences 2007, 64:2202-2210.